INGBER RAZI

PrivateCIK: 2113213

INGBER RAZI enters REDHILL BIOPHARMA LTD. with 277.56M shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderINGBER RAZICIK 2113213
IssuerREDHILL BIOPHARMA LTD.CIK 1553846
Officer· Chief Financial Officer
Since Mar 2026
277.56M
Baseline shares
100% direct
277.56M
Direct ownership
1 position
67.36M
Derivative underlying
5 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Ordinary Shares

Direct
Shares owned277.56M
Total
277.56M direct277.56M
Derivative Holdings5

American Depositary Shares

Direct
Underlying security
Ordinary Shares

Underlying shares

66.91M

Shares owned

N/A

Exercise price

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

230K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

30K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

20K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

170K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Total

Underlying

67.36M

Owned

0.00